CAR-T Therapy Won’t Raise Odds for a Second Cancer, Study Finds
WEDNESDAY, Sept. 11, 2024 (HealthDay News) — Contrary to a warning placed on labels for CART-T cancer therapies, use of these treatments does not appear to boost the odds for a secondary cancer later, a new study shows. Researchers at Memorial Sloan Kettering Cancer Center (MSKC) in New York CityContinue Reading